184 related articles for article (PubMed ID: 17768668)
21. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
[TBL] [Abstract][Full Text] [Related]
22. Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy.
Gonzalez EA; Visioli F; Pasqualim G; de Souza CFM; Marinho DR; Giugliani R; Matte U; Baldo G
Clin Exp Ophthalmol; 2020 Apr; 48(3):334-342. PubMed ID: 31925897
[TBL] [Abstract][Full Text] [Related]
23. Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships.
Al-Sannaa NA; Bay L; Barbouth DS; Benhayoun Y; Goizet C; Guelbert N; Jones SA; Kyosen SO; Martins AM; Phornphutkul C; Reig C; Pleat R; Fallet S; Ivanovska Holder I
Orphanet J Rare Dis; 2015 Oct; 10():131. PubMed ID: 26446585
[TBL] [Abstract][Full Text] [Related]
24. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).
Wraith JE; Beck M; Lane R; van der Ploeg A; Shapiro E; Xue Y; Kakkis ED; Guffon N
Pediatrics; 2007 Jul; 120(1):e37-46. PubMed ID: 17606547
[TBL] [Abstract][Full Text] [Related]
25. 18-year follow-up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I.
Pjetraj D; Santoro L; Sgattoni C; Padella L; Zampini L; Monachesi C; Gabrielli O; Catassi C
Am J Med Genet A; 2023 Feb; 191(2):564-569. PubMed ID: 36333985
[TBL] [Abstract][Full Text] [Related]
26. Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human alpha-L-iduronidase (laronidase, Aldurazyme).
Kloska A; Bohdanowicz J; Konopa G; Tylki-Szymńska A; Jakóbkiewicz-Banecka J; Czartoryska B; Liberek A; Wegrzyn A; Wegrzyn G
Am J Med Genet A; 2005 Dec; 139(3):199-203. PubMed ID: 16283671
[TBL] [Abstract][Full Text] [Related]
27. Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.
Jameson E; Jones S; Wraith JE
Cochrane Database Syst Rev; 2013 Sep; (9):CD009354. PubMed ID: 24085657
[TBL] [Abstract][Full Text] [Related]
28. [Hurler syndrome: early diagnosis and treatment].
Leroux S; Muller JB; Boutaric E; Busnel A; Lemouel F; Andro-Garçon M; Neven B; Valayannopoulos V; Vinceslas C
Arch Pediatr; 2014 May; 21(5):501-6. PubMed ID: 24698225
[TBL] [Abstract][Full Text] [Related]
29. Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.
Yamazaki N; Kosuga M; Kida K; Takei G; Fukuhara Y; Matsumoto H; Senda M; Honda A; Ishiguro A; Koike T; Yabe H; Okuyama T
Brain Dev; 2019 Jun; 41(6):546-550. PubMed ID: 30755342
[TBL] [Abstract][Full Text] [Related]
30. Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties.
Wraith JE
J Inherit Metab Dis; 2001 Apr; 24(2):245-50. PubMed ID: 11405343
[TBL] [Abstract][Full Text] [Related]
31. Scheie syndrome: enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression.
Illsinger S; Lücke T; Hartmann H; Mengel E; Müller-Forell W; Donnerstag F; Das AM
J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S321-5. PubMed ID: 19894140
[TBL] [Abstract][Full Text] [Related]
32. Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes.
Lund TC; Miller WP; Liao AY; Tolar J; Shanley R; Pasquali M; Sando N; Bigger BW; Polgreen LE; Orchard PJ
Sci Rep; 2019 Oct; 9(1):14105. PubMed ID: 31575939
[TBL] [Abstract][Full Text] [Related]
33. Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.
Langereis EJ; van Vlies N; Church HJ; Geskus RB; Hollak CE; Jones SA; Kulik W; van Lenthe H; Mercer J; Schreider L; Tylee KL; Wagemans T; Wijburg FA; Bigger BW
Mol Genet Metab; 2015 Feb; 114(2):129-37. PubMed ID: 25467058
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis.
Pérez-López J; Morales-Conejo M; López-Rodríguez M; Hermida-Ameijeiras Á; Moltó-Abad M
Mol Genet Metab; 2017 Jun; 121(2):138-149. PubMed ID: 28410878
[TBL] [Abstract][Full Text] [Related]
35. Enzyme replacement therapy in 12 patients with MPS I-H/S with homozygous p.Leu490Pro mutation.
Arora RS; Mercer J; Thornley M; Tylee K; Wraith JE
J Inherit Metab Dis; 2007 Oct; 30(5):821. PubMed ID: 17570076
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients.
Tylki-Szymanska A; Marucha J; Jurecka A; Syczewska M; Czartoryska B
J Inherit Metab Dis; 2010 Apr; 33(2):151-7. PubMed ID: 20217237
[TBL] [Abstract][Full Text] [Related]
37. Progression of organ manifestations upon enzyme replacement therapy in a patient with mucopolysaccharidosis type I/Hurler.
Mercimek-Mahmutoglu S; Reilly C; Human D; Waters PJ; Stoeckler-Ipsiroglu S
World J Pediatr; 2009 Nov; 5(4):319-21. PubMed ID: 19911152
[TBL] [Abstract][Full Text] [Related]
38. Laronidase treatment of mucopolysaccharidosis I.
Wraith EJ; Hopwood JJ; Fuller M; Meikle PJ; Brooks DA
BioDrugs; 2005; 19(1):1-7. PubMed ID: 15691212
[TBL] [Abstract][Full Text] [Related]
39. Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs.
Chiaro JA; O'Donnell P; Shore EM; Malhotra NR; Ponder KP; Haskins ME; Smith LJ
J Bone Miner Res; 2014 Dec; 29(12):2610-7. PubMed ID: 24898323
[TBL] [Abstract][Full Text] [Related]
40. Early Neonatal Cardiac Phenotype in Hurler Syndrome: Case Report and Literature Review.
Pillai NR; Ahmed A; Vanyo T; Whitley CB
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]